title: Prognostic relevance of CD20 expression in peripheral T-cell lymphomas: a multi-center retrospective study.
authors.affiliation: a Department of Hematology & Oncology , The University of Tokyo , Tokyo , Japan ;
authors.forename: Takashi
authors.initials: T
authors.lastname: Toya
authors.affiliation: a Department of Hematology & Oncology , The University of Tokyo , Tokyo , Japan ;
authors.forename: Yasuhito
authors.initials: Y
authors.lastname: Nannya
authors.affiliation: b Department of Hematology , NTT Medical Center Tokyo , Tokyo , Japan ;
authors.forename: Akira
authors.initials: A
authors.lastname: Hangaishi
authors.affiliation: c Department of Hematology , Tokyo Women's Medical University , Tokyo , Japan ;
authors.forename: Masayuki
authors.initials: M
authors.lastname: Shiseki
authors.affiliation: d Department of Medical Oncology , Tokyo Metropolitan Cancer and Infection diseases Center Komagome Hospital , Tokyo , Japan.
authors.forename: Tatsu
authors.initials: T
authors.lastname: Shimoyama
authors.affiliation: d Department of Medical Oncology , Tokyo Metropolitan Cancer and Infection diseases Center Komagome Hospital , Tokyo , Japan.
authors.forename: Hisashi
authors.initials: H
authors.lastname: Sakamaki
authors.affiliation: c Department of Hematology , Tokyo Women's Medical University , Tokyo , Japan ;
authors.forename: Toshiko
authors.initials: T
authors.lastname: Motoji
authors.affiliation: b Department of Hematology , NTT Medical Center Tokyo , Tokyo , Japan ;
authors.forename: Kensuke
authors.initials: K
authors.lastname: Usuki
authors.affiliation: a Department of Hematology & Oncology , The University of Tokyo , Tokyo , Japan ;
authors.forename: Fumihiko
authors.initials: F
authors.lastname: Nakamura
authors.affiliation: a Department of Hematology & Oncology , The University of Tokyo , Tokyo , Japan ;
authors.forename: Mineo
authors.initials: M
authors.lastname: Kurokawa
mesh_terms: D018951:Antigens, CD20 / Q000235:genetics / Q000378:metabolism*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001706:Biopsy; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005434:Flow Cytometry; D015870:Gene Expression; D006801:Humans; D053208:Kaplan-Meier Estimate; D016411:Lymphoma, T-Cell, Peripheral / Q000175:diagnosis / Q000188:drug therapy / Q000378:metabolism* / Q000401:mortality*; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D012189:Retrospective Studies; D016896:Treatment Outcome; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D018951:Antigens, CD20; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone